| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 28.153 | 101.662 | 121.632 | 130.272 | 149.217 | 150.918 | 158.573 | 168.970 | 183.512 |
| Total Income - EUR | 0 | 28.153 | 101.663 | 121.633 | 130.272 | 149.218 | 150.919 | 158.574 | 168.971 | 183.514 |
| Total Expenses - EUR | 5.622 | 18.433 | 63.178 | 74.357 | 95.186 | 99.665 | 95.910 | 98.141 | 100.904 | 127.990 |
| Gross Profit/Loss - EUR | -5.622 | 9.720 | 38.485 | 47.275 | 35.086 | 49.553 | 55.010 | 60.433 | 68.067 | 55.524 |
| Net Profit/Loss - EUR | -5.622 | 9.111 | 37.468 | 46.063 | 33.784 | 48.131 | 53.530 | 58.881 | 66.411 | 50.129 |
| Employees | 0 | 1 | 2 | 3 | 3 | 3 | 3 | 2 | 3 | 2 |
Check the financial reports for the company - Simnovomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 124 | 637 | 16.356 | 44.084 | 39.683 | 29.524 | 23.766 | 27.413 | 22.205 | 13.431 |
| Current Assets | 610 | 6.106 | 23.392 | 15.847 | 9.179 | 24.352 | 10.866 | 6.525 | 26.422 | 16.092 |
| Inventories | 522 | 2.639 | 5.108 | 4.441 | 4.144 | 2.150 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 248 | 243 | 704 | 2.535 | 2.063 | 3.838 | -2.271 | 8.185 | 788 |
| Cash | 88 | 3.219 | 18.041 | 10.703 | 2.500 | 20.138 | 7.029 | 8.796 | 18.237 | 15.304 |
| Shareholders Funds | -5.577 | 45 | 44 | 43 | 42 | 41 | 40 | 30.127 | 40 | 40 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.310 | 6.698 | 39.705 | 59.888 | 48.820 | 53.835 | 34.592 | 3.811 | 48.586 | 29.483 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Simnovomed Srl